These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20955290)
1. Regulation of xenogeneic porcine pancreatic islets. Arcidiacono JA; Evdokimov E; Lee MH; Jones J; Rudenko L; Schneider B; Snoy PJ; Wei CH; Wensky AK; Wonnacott K Xenotransplantation; 2010; 17(5):329-37. PubMed ID: 20955290 [TBL] [Abstract][Full Text] [Related]
2. Diabetes trial stirs debate on safety of xenotransplants. Check E Nature; 2002 Sep; 419(6902):5. PubMed ID: 12214198 [No Abstract] [Full Text] [Related]
3. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework. Cozzi E; Tallacchini M; Flanagan EB; Pierson RN; Sykes M; Vanderpool HY Xenotransplantation; 2009; 16(4):203-14. PubMed ID: 19799760 [TBL] [Abstract][Full Text] [Related]
4. Xenogeneic transplantation of porcine islets: an overview. MacKenzie DA; Hullett DA; Sollinger HW Transplantation; 2003 Sep; 76(6):887-91. PubMed ID: 14508349 [TBL] [Abstract][Full Text] [Related]
6. [Isolation of islands of Langerhans from human and porcine pancreas for transplantation to humans]. Brandhorst D; Brandhorst H; Brendel M; Bretzel RG Zentralbl Chir; 1998; 123(7):814-22. PubMed ID: 9746981 [TBL] [Abstract][Full Text] [Related]
7. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 3: Porcine islet product manufacturing and release testing criteria. Rayat GR; Gazda LS; Hawthorne WJ; Hering BJ; Hosking P; Matsumoto S; Rajotte RV Xenotransplantation; 2016; 23(1):38-45. PubMed ID: 26923763 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of microencapsulated porcine islets. Sun AM; Vacek I; Sun YL; Ma X; Zhou D ASAIO J; 1992; 38(2):125-7. PubMed ID: 1421606 [TBL] [Abstract][Full Text] [Related]
9. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials. Vanderpool HY Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766 [TBL] [Abstract][Full Text] [Related]
10. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Executive summary. Hering BJ; Cozzi E; Spizzo T; Cowan PJ; Rayat GR; Cooper DK; Denner J Xenotransplantation; 2016; 23(1):3-13. PubMed ID: 26940725 [TBL] [Abstract][Full Text] [Related]
12. Update on regulatory issues in pancreatic islet transplantation. Wonnacott K Am J Ther; 2005; 12(6):600-4. PubMed ID: 16280654 [TBL] [Abstract][Full Text] [Related]
13. National policies for xenotransplantation in the USA. Bloom ET Xenotransplantation; 2007 Jul; 14(4):345-6. PubMed ID: 17669177 [TBL] [Abstract][Full Text] [Related]
14. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-- executive summary. Hering BJ; Cooper DK; Cozzi E; Schuurman HJ; Korbutt GS; Denner J; O'Connell PJ; Vanderpool HY; Pierson RN Xenotransplantation; 2009; 16(4):196-202. PubMed ID: 19799759 [TBL] [Abstract][Full Text] [Related]
15. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses. Denner J; Schuurman HJ; Patience C Xenotransplantation; 2009; 16(4):239-48. PubMed ID: 19799764 [TBL] [Abstract][Full Text] [Related]
16. [Transplantation of islets of langerhans--alternative or solution in type 1 diabetes treatment?]. Lepich T; Wilk R; Dabek J; Piwowarczyk A; Kuczera B; Gielecki JS Wiad Lek; 2005; 58(7-8):437-41. PubMed ID: 16425799 [TBL] [Abstract][Full Text] [Related]
17. FDA seeks "comfort factors" before removing hold on porcine xenotransplantation trials. Fox JL Nat Biotechnol; 1998 Mar; 16(3):224. PubMed ID: 9527996 [No Abstract] [Full Text] [Related]
18. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 2b: genetically modified source pigs. Cowan PJ; Ayares D; Wolf E; Cooper DK Xenotransplantation; 2016; 23(1):32-7. PubMed ID: 26926888 [TBL] [Abstract][Full Text] [Related]
19. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing. Korbutt GS Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762 [TBL] [Abstract][Full Text] [Related]